Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quarterly results round-up: Dentsply and Thoratec see double-digit sales growth, while Fresenius doubles income

This article was originally published in Clinica

Executive Summary

Dental implant firm Dentsply International reported impressive 26% revenue growth during its first fiscal quarter of 2012 at $716.4m. However, the firm saw its Q1 net income slip to $53.3m or $0.37 per diluted share, compared with $69.1m or $0.48 per diluted share during the same period last year, as it was hit by increased expenses and restructuring costs. On an adjusted basis, earnings increased to $0.52 per share from $0.50 per diluted share in last year's Q1.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT098885

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel